Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal
Michael Benatar, Joanne Wuu, Martin R. Turner
Brain (2022) Vol. 146, Iss. 7, pp. 2711-2716
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Fluid biomarkers for amyotrophic lateral sclerosis: a review
Katherine E. Irwin, Udit Sheth, Philip C. Wong, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 28
Targeting mitophagy in neurodegenerative diseases
Odetta Antico, Paul Thompson, Nicholas T. Hertz, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 11
The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization
Amanda M. Leisgang Osse, Jefferson W. Kinney, Jeffrey L. Cummings
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Michael Benatar, Thomas Michael Hansen, Dror Rom, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 7, pp. 687-699
Closed Access | Times Cited: 16
The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology
Michael Benatar, Joanne Wuu, Edward D. Huey, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 6, pp. 364-376
Open Access | Times Cited: 12
Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter study
Thomas Meyer, Marie Dreger, Torsten Grehl, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 9
Open Access | Times Cited: 12
Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis
Michael Benatar, Eric A. Macklin, Andrea Malaspina, et al.
EBioMedicine (2024) Vol. 108, pp. 105323-105323
Open Access | Times Cited: 8
Biomarkers for Managing Neurodegenerative Diseases
Lara Cheslow, Adam E. Snook, Scott A. Waldman
(2024)
Open Access | Times Cited: 6
Biomarker Qualification for Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: Theory and Practice
Michael Benatar, Lyle W. Ostrow, Joseph W. Lewcock, et al.
Annals of Neurology (2023) Vol. 95, Iss. 2, pp. 211-216
Open Access | Times Cited: 14
Biomarkers for Managing Neurodegenerative Diseases
Lara Cheslow, Adam E. Snook, Scott A. Waldman
Biomolecules (2024) Vol. 14, Iss. 4, pp. 398-398
Open Access | Times Cited: 5
Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post‐onset ΔFS for study design and medical practice
Albert C. Ludolph, Philippe Corcia, Claude Desnuelle, et al.
Muscle & Nerve (2024) Vol. 70, Iss. 1, pp. 36-41
Closed Access | Times Cited: 5
A microRNA diagnostic biomarker for amyotrophic lateral sclerosis
Sandra Anne Banack, Rachael A. Dunlop, Paul Mehta, et al.
Brain Communications (2024) Vol. 6, Iss. 5
Open Access | Times Cited: 5
Presymptomatic amyotrophic lateral sclerosis: from characterization to prevention
Michael Benatar, Martin R. Turner, Joanne Wuu
Current Opinion in Neurology (2023) Vol. 36, Iss. 4, pp. 360-364
Closed Access | Times Cited: 13
Blood level of neurofilament light chain as a biomarker for neurological disorders
Martin R. Turner, Alexander G. Thompson, Charlotte E. Teunissen
BMJ Medicine (2025) Vol. 4, Iss. 1, pp. e000958-e000958
Open Access
Unlocking the Mysteries of Rare Disease Drug Development: A Beginner's Guide for Clinical Pharmacologists
Mariam A. Ahmed, Bilal Abuasal, Jeffrey S. Barrett, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 4
Open Access
Skeletal muscle biomarkers of amyotrophic lateral sclerosis: a large-scale, multi-cohort proteomic study
Oleksandr Dergai, Joanne Wuu, Magdalena Koziczak‐Holbro, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
ICAM-1 and IL-10 are associated with cognitive dysfunction using the MoCA test in glioma: findings from the NCI Neuro-Oncology Branch Natural History Study
Kaitlynn Slattery, McKenzie C. Kauss, Dhaivat Raval, et al.
Neuro-Oncology Advances (2025)
Open Access
Phosphorylated neurofilament heavy chain (pNfH) concentration in cerebrospinal fluid predicts overall disease aggressiveness (D50) in amyotrophic lateral sclerosis
Julia Meyer, Nayana Gaur, Janina von der Gablentz, et al.
Frontiers in Neuroscience (2025) Vol. 19
Open Access
Pathophysiology, Clinical Heterogeneity, and Therapeutic Advances in Amyotrophic Lateral Sclerosis: A Comprehensive Review of Molecular Mechanisms, Diagnostic Challenges, and Multidisciplinary Management Strategies
Manuel Gónzalez-Sánchez, Marı́a Jesús Ramı́rez-Expósito, José Manuel Martı́nez-Martos
Life (2025) Vol. 15, Iss. 4, pp. 647-647
Open Access
Motor phenotypes of amyotrophic lateral sclerosis – a three-determinant anatomical classification based on the region of onset, propagation of motor symptoms, and the degree of upper and lower motor neuron dysfunction
Thomas Meyer, Matthias Boentert, Julian Großkreutz, et al.
Neurological Research and Practice (2025) Vol. 7, Iss. 1
Open Access
Examining the evidence for IL-2 in amyotrophic lateral sclerosis
Michael Benatar, Michael McDermott
The Lancet (2025)
Closed Access
Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis
Luisa Donini, Raffaella Tanel, Riccardo Zuccarino, et al.
Neuroscience Research (2023) Vol. 197, pp. 31-41
Open Access | Times Cited: 9
Biofluid Biomarkers in the Prognosis of Amyotrophic Lateral Sclerosis: Recent Developments and Therapeutic Applications
Daniel Sánchez‐Tejerina, Arnau Llauradó, J. Sotoca, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1180-1180
Open Access | Times Cited: 8
Biomarkers for predicting disease course in Sanfilippo syndrome: An urgent unmet need in childhood‐onset dementia
Leanne K. Winner, Mary‐Louise Rogers, Marten F. Snel, et al.
Journal of Neurochemistry (2023) Vol. 166, Iss. 3, pp. 481-496
Open Access | Times Cited: 8
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Mary‐Louise Rogers, David Schultz, Vassilios Karnaros, et al.
Brain Communications (2023) Vol. 5, Iss. 6
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top